Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

By HospiMedica International staff writers
Posted on 15 Mar 2024

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons to quickly identify any bleeding to prevent minor bleeds from turning into serious complications. Now, a novel monitoring device offers real-time detection of bleeding during endovascular procedures, ensuring better outcomes and providing peace of mind for patients at high risk of bleeding.

The Early Bird Bleed Monitoring System (EBBMS) from Saranas, Inc. (Houston, TX, USA) is the only FDA-approved system for real-time bleed monitoring, marking a significant step forward in reducing healthcare expenses and enhancing patient care during endovascular procedures. The system employs the Bleed Detection Array to generate bioimpedance signals that track bleeding status, with simple indicators alerting surgeons to potential bleeds and signaling when intervention is necessary. Both animal studies and clinical trials have consistently shown a direct correlation between reduced bioimpedance levels and increased bleed volume. Early Bird can identify bleed progression with a statistically significant increase in volume detected at each bleed indicator level.

The "SAFE-MCS" study, a multi-center U.S. clinical trial, has assessed the safety of performing complex, high-risk percutaneous coronary interventions (PCI) with mechanical circulatory support (MCS) and monitoring with EBBMS. PCI is a non-surgical method for treating coronary artery blockages and restoring blood flow to the heart. This study, involving 203 patients from various U.S. centers, showcased EBBMS's capability to identify and mitigate bleeding complications during protected PCI. Protected PCI, which uses MCS to temporarily support the heart's pumping action, is a recognized treatment method. This pioneering study focused on bleeding complications during protected PCI, highlighting a significant decline in such complications among patients monitored with EBBMS.

 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Multi-Parameter Patient Monitor
S90
New
Imaging Table
CFPM200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.